Industry news

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

US Educational Support Service for MS Community, MS LifeLines
Geneva, Switzerland, September 1, 2010 - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that MS LifeLines, a US educational and support service which includes a call center, has achieved...

Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
ROCKVILLE, Md., September 1, 2010 -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. (Diosynth) for the...

LGC and China Association for Standardisation sign Memorandum of Understanding
September 01, 2010 -- LGC, an international science-based company and recognised leader in chemical and bioanalytical services and reference materials, has signed a Memorandum of Understanding (MOU) with the China...

3M to Acquire Attenti Holdings S.A.
ST. PAUL, Minn. & TEL AVIV, Israel--August 31, 2010--3M announced today it has entered into a definitive agreement to acquire Attenti Holdings S.A. from an investor group led by Francisco Partners, for a purchase...

GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Marlborough, MA, August 31, 2010 - Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility...

SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
BOTHELL, Wash., Aug. 30, 2010 -- SCOLR Pharma, Inc. (NYSE AMEX: DDD) today announced that it has signed an agreement with The Emerson Group to provide sales support for the Company's new line of extended-release...

Meda acquires Alaven, a US specialty pharma company
August 30, 2010 -- Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda's marketing capabilities in the US and expand the therapeutic...

3M to Acquire Cogent Inc.
ST. PAUL, Minn. & PASADENA, Calif.--August 30, 2010--3M (NYSE:MMM), and Cogent Inc. (NASDAQ:COGT) announced today that they have entered into a definitive agreement for 3M's acquisition of Cogent Inc. for $10.50 per...

Intendis and KYTHERA Enter Licensing and Development Agreement on Adipolytic Agent for Aesthetic Dermatology Use
Berlin, August 30, 2010 -- Bayer HealthCare's dermatology business Intendis and KYTHERA Biopharmaceuticals, Inc. today announced an agreement to develop and commercialize ATX-101; an adipolytic agent designed to...

Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions
Basel, Switzerland, 30 August 2010 - Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions, Inc. The acquisition advances Lonza's strategy to broaden its biologics custom...

Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions
Basel, Switzerland, 30 August 2010 - Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions, Inc. The acquisition advances Lonza's strategy to broaden its biologics custom...

Ensign-Bickford Industries, Inc., Acquires EnviroLogix Inc.
(Simsbury, CT, August 30, 2010) As part of its business growth and diversification strategy, Ensign-Bickford Industries, Inc. "EBI" announced today that its subsidiary, EB Analytics, Inc. has acquired EnviroLogix...

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology
Rockville, MD - August 30, 2010- Sequella, Inc., a clinical-stage company focused on commercialization of novel drugs for life-threatening infectious diseases, announced today the restatement of its exclusive...

Pluristem's Placenta Derived Cells Chosen by European Commission's Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients
HAIFA, ISRAEL --August 30, 2010--Pluristem Therapeutics Inc. (NasdaqCM: PSTI; DAX: PJT) today announced that its PLX cell therapy product, derived from human placenta, a non-controversial, non embryonic, adult stem...

Misonix Announces New Distribution Agreement for Russia
FARMINGDALE, N.Y., Aug 27, 2010 -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new,...

Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment
CAMBRIDGE, Mass.--August 27, 2010--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt,...

Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment
CAMBRIDGE, Mass., Aug 27, 2010 -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt,...

Exactech Acquires Minimally Invasive Spine Reconstruction Portfolio
GAINESVILLE, Fla. - August 27, 2010 - Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the...

The Institute of Cancer Research and Horizon Discovery to Collaborate on Genome-wide Synthetic-lethality Screens
August 27, 2010 - The Institute of Cancer Research (ICR) and Horizon Discovery (Horizon) are forming a collaboration aimed at rapidly screening the human genome for novel drug targets that selectively kill cancer cells.

McKesson and HFMA Join Forces to Offer Health Reform Webinar Series
August 26, 2010 - The industry leader in revenue cycle management solutions and the leading membership organization for healthcare financial management leaders are collaborating to offer healthcare providers the...

Abbott Provides Initial Support for Flood Relief Efforts in Pakistan
Karachi, Pakistan -- August 25, 2010 - Abbott (NYSE: ABT) and its philanthropic foundation the Abbott Fund are providing $335,000 (Rs 28.7 million) in initial humanitarian aid to help with flood relief efforts in...

Austrian BIOCRATES Life Sciences AG and Swiss Selexis SA join forces to further optimize high-yield mammalian cell cultures for the production of protein pharmaceuticals
Innsbruck, 19 August 2010---Austrian BIOCRATES Life Sciences AG and Swiss Selexis SA have entered into a co-development agreement to further increase drug substance yields from mammalian cell cultures. Because most...

Achillion Announces Private Placement of $50 Million
NEW HAVEN, Conn., Aug. 18, 2010 -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced...

PPD Declares Third Quarter Dividend
WILMINGTON, N.C. (August 17, 2010) -- PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the third quarter of 2010 under its annual cash dividend policy. The quarterly...

EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103 ACQUISITION OF SHARES OF AMORFIX LIFE SCIENCES
TORONTO, Ontario - August 16, 2010 - This press release is being disseminated as required by National Instrument 62-103 The Early Warning System and Related Take Over Bids and Insider Reporting Issues in connection...

Orphagen Pharmaceuticals Awarde Federal Grant for Adrenocortical and Prostate Cancer
San Diego, August 10, 2010 - Orphagen Pharmaceuticals announced today that the National Cancer Institute (NCI) has awarded a Phase I SBIR grant to the Company for development of a new class of small molecule drugs...

ADVENTRX Engages Canaccord Genuity as Product Acquisition Advisor
SAN DIEGO, Aug 10, 2010 --ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that it has engaged the investment banking firm Canaccord Genuity Inc. to advise the Company and its Board of Directors as it...

Pluristem's PLX Cells Found to be Effective in Treating Neuropathic and Inflammatory Pain
HAIFA, Israel-- August 09, 2010--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced the results of two separate pre-clinical studies in animal models which demonstrated that its PLacental...

Ranier Technology announces the European Patent Grant on its Precision Polyurethane Manufacturing (PPM) Technology
July 15, 2010--Cambridge, UK based Ranier Technology announced that they have received the grant of a European Patent for its Precision Polyurethane Manufacturing (PPM) materials manufacturing technology.

The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for StemEx
Jerusalem, Israel, June 21, 2010 --- Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow...

Orphagen Pharmaceuticals Awarded Phase 2 SBIR Funding to Investigate Novel Drug Class for CNS Disorders
San Diego, February 1, 2010-- Orphagen Pharmaceuticals announced today that it has been awarded a twoyear federal grant to further characterize a novel class of small molecule drugs with potential to treat circadian...